Madrigal Pharmaceuticals
Mr. Chiang has over 20 years of clinical trial experience starting his career at Bracco Diagnostics developing ultrasound contrast agents, followed by roles at Beacon Biosciences (now Icon Medical Imaging) and VIA Pharmaceuticals. Mr. Chiang joined Dr. Taub when she founded Madrigal and was directly involved in Madrigal’s initial Phase 1 and 2 clinical trials.
This person is not in any teams
Madrigal Pharmaceuticals
4 followers
Madrigal Pharmaceuticals is a clinical-stage biopharmaceutical company pursuing novel therapeutics that target a specific thyroid hormone receptor pathway in the liver, which is a key regulatory mechanism common to a spectrum of cardio-metabolic and fatty liver diseases with high unmet medical need.